Patents by Inventor James C. D. Hengst

James C. D. Hengst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170107585
    Abstract: The present invention discloses positive control material for nucleic acid amplification based detection of microorganisms in biological samples. The control material comprises purified microorganism that is rendered non-infectious but is amenable to nucleic acid amplification. Also disclosed is a process for making and using the control material.
    Type: Application
    Filed: December 29, 2016
    Publication date: April 20, 2017
    Inventors: James C.D. Hengst, Gregory R. Chiklis
  • Publication number: 20150368727
    Abstract: The present invention discloses positive control material for nucleic acid amplification based detection of microorganisms in biological samples. The control material comprises purified microorganism that is rendered non-infectious but is amenable to nucleic acid amplification. Also disclosed is a process for making and using the control material.
    Type: Application
    Filed: August 31, 2015
    Publication date: December 24, 2015
    Inventors: James C.D. Hengst, Gregory R. Chiklis
  • Patent number: 9127048
    Abstract: The present invention discloses positive control material for nucleic acid amplification based detection of microorganisms in biological samples. The control material comprises purified microorganism that is rendered non-infectious but is amenable to nucleic acid amplification. Also disclosed is a process for making and using the control material.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 8, 2015
    Assignee: ZeptoMetrix Corporation
    Inventors: Gregory R. Chiklis, James C. D. Hengst
  • Patent number: 9120849
    Abstract: The present invention discloses positive control material for nucleic acid amplification based detection of microorganisms in biological samples. The control material comprises purified microorganism that is rendered non-infectious but is amenable to nucleic acid amplification. Also disclosed is a process for making and using the control material.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 1, 2015
    Assignee: ZeptoMetrix Corporation
    Inventors: Gregory R. Chiklis, James C. D. Hengst
  • Patent number: 5807752
    Abstract: The invention relates to a test system useful in carrying out diagnostic assays. One component of the test system is an unblocked solid phase test carrier with a three dimensional configuration, impregnated with a first binding partner for analyte of interest. The second component of a binding agent containing a second binding partner coupled to an immediately visually determinable label, and a blocking agent. Rapid and accurate assays may be carried out by using the described system.
    Type: Grant
    Filed: September 11, 1992
    Date of Patent: September 15, 1998
    Assignee: Boehringer Mannheim Corporation
    Inventors: Marius Brizgys, Bernd Hilger, James C. D. Hengst, David Webster, Harvey Buck